Found: 19
Select item for more details and to access through your institution.
Safety Profile of Pertuzumab With Trastuzumab and Docetaxel in Patients From Asia With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Results From the Phase III Trial CLEOPATRA.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Prognostic Value of Interim Positron Emission Tomography in Patients With Peripheral T-Cell Lymphoma.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
The European Medicines Agency Review of Pertuzumab for the Treatment of Adult Patients With HER2-PositiveMetastatic or Locally Recurrent Unresectable Breast Cancer: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Prognostic Value of Interim Positron Emission Tomography in Patients With Peripheral T-Cell Lymphoma.
- Published in:
- Oncologist, 2014, v. 19, n. 7, p. 746, doi. 10.1634/theoncologist.2013-0463
- By:
- Publication type:
- Article
Seizure Prognosis in Brain Tumors: New Insights and Evidence-Based Management.
- Published in:
- Oncologist, 2014, v. 19, n. 7, p. 751, doi. 10.1634/theoncologist.2014-0060
- By:
- Publication type:
- Article
Adolescents and Young Adults With a “Rare” Cancer: Getting Past Semantics to Optimal Care for Patients With Germ Cell Tumors.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Quality of Life in the Trastuzumab for Gastric Cancer Trial.
- Published in:
- Oncologist, 2014, v. 19, n. 7, p. 712, doi. 10.1634/theoncologist.2014-0058
- By:
- Publication type:
- Article
Patterns of Storage, Use, and Disposal of Opioids Among Cancer Outpatients.
- Published in:
- Oncologist, 2014, v. 19, n. 7, p. 780, doi. 10.1634/theoncologist.2014-0071
- By:
- Publication type:
- Article
6-Thioguanine: A Drug With Unrealized Potential for Cancer Therapy.
- Published in:
- Oncologist, 2014, v. 19, n. 7, p. 760, doi. 10.1634/theoncologist.2014-0178
- By:
- Publication type:
- Article
Safety Profile of Pertuzumab With Trastuzumab and Docetaxel in Patients From Asia With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Results From the Phase III Trial CLEOPATRA.
- Published in:
- Oncologist, 2014, v. 19, n. 7, p. 693, doi. 10.1634/theoncologist.2014-0033
- By:
- Publication type:
- Article
U.S.Food and Drug Administration Approval Summary:Erlotinib for the First-Line Treatment of Metastatic Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor Exon 19 Deletions or Exon 21 (L858R) Substitution Mutations.
- Published in:
- Oncologist, 2014, v. 19, n. 7, p. 774, doi. 10.1634/theoncologist.2014-0089
- By:
- Publication type:
- Article
The Challenging World of Cytopenias: Distinguishing Myelodysplastic Syndromes From Other Disorders of Marrow Failure.
- Published in:
- Oncologist, 2014, v. 19, n. 7, p. 735, doi. 10.1634/theoncologist.2014-0056
- By:
- Publication type:
- Article
Effect of M1a and M1b Category in Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2014, v. 19, n. 7, p. 720, doi. 10.1634/theoncologist.2013-0442
- By:
- Publication type:
- Article
Cervical Cancer in Ethiopia: Survival of 1,059 Patients Who Received Oncologic Therapy.
- Published in:
- Oncologist, 2014, v. 19, n. 7, p. 727, doi. 10.1634/theoncologist.2013-0326
- By:
- Publication type:
- Article
Current Status of Gene Expression Profiling to Assist Decision Making in Stage II Colon Cancer.
- Published in:
- Oncologist, 2014, v. 19, n. 7, p. 704, doi. 10.1634/theoncologist.2013-0471
- By:
- Publication type:
- Article
The Untimely Passing of a Great Man: Eddie Reed, M.D., 1953-2014.
- Published in:
- 2014
- By:
- Publication type:
- Obituary
Cervical Brachytherapy Exchange: Steps Toward Oncology Capacity Building in Botswana.
- Published in:
- 2014
- By:
- Publication type:
- Letter to the Editor
The European Medicines Agency Review of Pertuzumab for the Treatment of Adult Patients With HER2-PositiveMetastatic or Locally Recurrent Unresectable Breast Cancer: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use
- Published in:
- Oncologist, 2014, v. 19, n. 7, p. 766, doi. 10.1634/theoncologist.2013-0348
- By:
- Publication type:
- Article
Phase II Study of Afatinib as Third-Line Treatment for Patients in Korea With Stage IIIB/IV Non-Small Cell Lung Cancer Harboring Wild-Type EGFR.
- Published in:
- Oncologist, 2014, v. 19, n. 7, p. 702, doi. 10.1634/theoncologist.2013-0419
- By:
- Publication type:
- Article